5gji Citations

Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins.

J Biol Chem 292 1052-1060 (2017)
Related entries: 5aul, 5gjh

Cited: 11 times
EuropePMC logo PMID: 27927989

Abstract

Full activation of T cells and differentiation into effector T cells are essential for many immune responses and require co-stimulatory signaling via the CD28 receptor. Extracellular ligand binding to CD28 recruits protein-tyrosine kinases to its cytoplasmic tail, which contains a YMNM motif. Following phosphorylation of the tyrosine, the proteins growth factor receptor-bound protein 2 (Grb2), Grb2-related adaptor downstream of Shc (Gads), and p85 subunit of phosphoinositide 3-kinase may bind to pYMNM (where pY is phosphotyrosine) via their Src homology 2 (SH2) domains, leading to downstream signaling to distinct immune pathways. These three adaptor proteins bind to the same site on CD28 with variable affinity, and all are important for CD28-mediated co-stimulatory function. However, the mechanism of how these proteins recognize and compete for CD28 is unclear. To visualize their interactions with CD28, we have determined the crystal structures of Gads SH2 and two p85 SH2 domains in complex with a CD28-derived phosphopeptide. The high resolution structures obtained revealed that, whereas the CD28 phosphopeptide bound to Gads SH2 is in a bent conformation similar to that when bound to Grb2 SH2, it adopts a more extended conformation when bound to the N- and C-terminal SH2 domains of p85. These differences observed in the peptide-protein interactions correlated well with the affinity and other thermodynamic parameters for each interaction determined by isothermal titration calorimetry. The detailed insight into these interactions reported here may inform the development of compounds that specifically inhibit the association of CD28 with these adaptor proteins to suppress excessive T cell responses, such as in allergies and autoimmune diseases.

Reviews - 5gji mentioned but not cited (1)

  1. Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design. Singh SS, Jois SD. Adv Protein Chem Struct Biol 111 1-59 (2018)

Articles - 5gji mentioned but not cited (3)



Reviews citing this publication (2)

  1. SH2 Domain Binding: Diverse FLVRs of Partnership. Jaber Chehayeb R, Boggon TJ. Front Endocrinol (Lausanne) 11 575220 (2020)
  2. Recent Advances in Allogeneic CAR-T Cells. Kim DW, Cho JY. Biomolecules 10 (2020)

Articles citing this publication (5)

  1. Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK. Clayton NS, Fox M, Vicenté-Garcia JJ, Schroeder CM, Littlewood TD, Wilde JI, Krishnan K, Brown MJB, Crafter C, Mott HR, Owen D. J Biol Chem 298 101916 (2022)
  2. Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases. Li X, Lau AYT, Ng ASN, Aldehaiman A, Zhou Y, Ng PKS, Arold ST, Cheung LWT. Proc Natl Acad Sci U S A 118 e2101751118 (2021)
  3. Incorporation of Oxidized Phenylalanine Derivatives into Insulin Signaling Relevant Proteins May Link Oxidative Stress to Signaling Conditions Underlying Chronic Insulin Resistance. Mohás-Cseh J, Molnár GA, Pap M, Laczy B, Vas T, Kertész M, Németh K, Hetényi C, Csikós O, Tóth GK, Reményi A, Wittmann I. Biomedicines 10 975 (2022)
  4. Effects of active site residues of 3α-hydroxysteroid dehydrogenase from pseudomonas sp. b-0831 on its catalysis and cofactor binding. Shiota A, Inaba S, Oda M. Biosci. Biotechnol. Biochem. 82 1702-1707 (2018)
  5. Structural and functional properties of Grb2 SH2 dimer in CD28 binding. Hosoe Y, Numoto N, Inaba S, Ogawa S, Morii H, Abe R, Ito N, Oda M. Biophys Physicobiol 16 80-88 (2019)